Dopamine antagonism in a novel-object recognition and a novel-object place conditioning preparation with rats

Behavioural Brain Research

Volumn 103, Issue 1, 1999, Pages 35-44

  Besheer, Joyce ^a   Jensen, Heather C ^a   Bevins, Rick A ^a  

^a Nebraska Behavioral Biology Group   (United States)

Author keywords

Cocaine; Eticlopride; Novelty, Pavlovian conditioning; Object recognition; Place preference; Reward; SCH 23390

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR BLOCKING AGENT; ETICLOPRIDE;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; CONDITIONING; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DRUG EFFECT; MALE; MOTOR PERFORMANCE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RECOGNITION; STATE DEPENDENT LEARNING;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BEHAVIOR, ANIMAL; COGNITION; CONDITIONING, OPERANT; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SALICYLAMIDES;

EID: 0032860130     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(99)00021-2     Document Type: Article

References (39)

1. Acquas E., Di Chiara G. D1 receptor blockade stereospecifically impairs the acquisition of drug-conditioned place preference and place aversion. Behav Pharmacol. 5:1994;555-569.
2. Aggleton J.P., Keen S., Warburton E.C., Bussey T.J. Extensive cytotoxic lesions involving both the rhinal cortices and area TE impair recognition but spare spatial alternation in the rat. Brain Res Bull. 43:1997;279-287.
3. Ball S.A., Carroll K.M., Rounsaville B.J. Sensation seeking, substance abuse, and psychopathology in treatment-seeking and community cocaine abusers. J Consult Clin Pscyhol. 62:1994;1053-1057.
4. Bardo M.T., Neisewander J.L., Pierce R.C. Novelty-induced place preference behavior in rats: Effects of opiate and dopaminergic drugs. Pharmacol Biochem Behav. 32:1989;683-689.
5. 2 receptors in novelty-maintained place preference. Exp Clin Psychopharmacol. 1:1993;101-109.
6. Bardo M.T., Donohew R.L., Harrington N.G. Psychobiology of novelty seeking and drug seeking behavior. Behav Brain Res. 77:1996;23-43.
7. Beninger R.J., Miller R. Dopamine D1-like receptors and reward-related incentive learning. Neurosci Biobehav Rev. 22:1998;335-345.
8. Bevins R.A., Klebaur J.E., Bardo M.T. Individual differences in response to novelty and amphetamine drug discrimination in rats. Behav Pharmacol. 8:1997;113-123.
9. Bevins R.A., Bardo M.T. Conditioned increase in place preference by access to novel objects: Antagonism by MK-801. Behav. Brain Res. 99:1999;53-60.
10. 3 dopamine receptor: pharmacologic properties and development of antibodies. J Pharmacol Exp Ther. 264:1993;1002-1011.
11. Carr G.D., Fibiger H.C., Phillips A.G. Conditioned place preference as a measure of drug reward. Liebman J.M., Cooper S.J. The Neuropharmacological Basis of Reward. 1989;264-319 Oxford University Press, New York.
12. Cervo L., Samanin R. Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res. 673:1995;242-250.
13. Cloninger C.R. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 44:1987;573-588.
14. Cloninger C.R., Sigvardsson S., Przybeck T.R., Svrakic D.M. Personality antecedents of alcoholism in a national area probability sample. Eur Arch Psychiatry Clin Neurosci. 245:1995;239-244.
15. Deschaux O., Bizot J.C., Goyffon M. Apamin improves learning in an object recognition task in rats. Neurosci Lett. 222:1997;159-162.
16. Donohew L., Helm D., Lawrence P., Shatzer M. Sensation seeking, marijuana use and responses to prevention messages: implication for public health campaigns. Watson R. Prevention and Treatment of Drug and Alcohol Abuse. 1990;77-93 Humana, Clifton, NJ.
17. Ennaceur A., Delacour J. A new-one trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res. 31:1988;47-59.
18. Fagan J.F. Memory in the infant. J Exp Child Psychol. 9:1970;217-226.
19. Harrington N.G., Donohew L. Jump start: a targeted substance abuse prevention program. Health Educ Behav. 24:1997;568-586.
20. Hiroi N., White N.M. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain Res. 552:1991;141-152.
21. Hughes R.N. Food deprivation and locomotor exploration in the white rat. Anim Behav. 13:1965;30-32.
22. Hughes R.N. Intrinsic exploration in animals: motives and measurement. Behav Processes. 41:1997;213-226.
23. Kalichman S.C., Rompa D. Sexual sensation seeking and Sexual Compulsivity Scales: reliability, validity, and predicting HIV risk behavior. J Pers Assess. 65:1995;586-601.
24. Kalichman S.C., Heckman T., Kelly J.A. Sensation seeking as an explanation for the association between substance use and HIV-related risky sexual behaviors. Arch Sex Behav. 25:1996;141-154.
25. Köhler C., Hall H., Gawell L. Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labeling of dopamine receptors. Eur J Pharmacol. 120:1986;217-226.
26. Leone P., Di Chiara G. Blockade of D-1 receptors by SCH-23390 antagonizes morphine-and amphetamine-induced place preference conditioning. Eur J Pharmacol. 135:1987;251-254.
27. Morency M.A., Beninger R.J. Dopaminergic substrates of cocaine-induced place conditioning. Brain Res. 399:1986;33-41.
28. Phillips R.G., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci. 106:1992;274-285.
29. Pierce R.C., Crawford C.A., Nonneman A.J., Mattingly B.A., Bardo M.T. Effect of forebrain dopamine depletion on novelty-induced place preference behavior in rats. Pharmacol Biochem Behav. 36:1990;321-325.
30. Puma C., Baudoin C., Bizot J.-C. Effects of intraseptal infusions of N-methyl-D-aspartate receptor ligands on memory in an object recognition task in rats. Neurosci Lett. 244:1998;97-100.
31. Rebec G.V., Grabner C.P., Johnson M., Pierce R.C., Bardo M.T. Transient increases in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty. Neuroscience. 76:1997;707-714.
32. Rebec G.V., Christensen J.R.C., Guerra C., Bardo M.T. Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty. Brain Res. 776:1997;61-67.
33. Scali C., Giovannini M.G., Prosperi C., Bartolini L., Pepeu G. Tacrine administration enhances extracellular acetylcholine in vivo and restores the cognitive impairment in aged rats. Pharmacol Res. 36:1997;463-469.
34. 1 receptor pharmacology. ISI Atlas Sci: Pharmacol, 1988:161-70.
35. Seeman P., VanTol H.H.M. Dopamine receptor pharmacology. Trends Pharmacol Sci. 15:1994;264-270.
36. Sheldon A.B. Preference for familiar versus novel stimuli as a function of the familiarity of the environment. J Comp Physiol Psychol. 67:1969;516-521.
37. Shippenberg T.S., Herz A. Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. Eur J Pharmacol. 151:1988;233-242.
38. Winnicka M.M., Braszko J.J. 6-OHDA lesions to the central amygdala abolish angiotensins facilitation of object recognition in rats. Gen Pharmacol. 29:1997;239-243.
39. Zuckerman M. Sensation-seeking: Beyond the Optimal Level of Arousal. 1979;Lawrence Erlbaum Associates, Hillsdale, NJ.